Search Results 781-790 of 17565 for Assay
TP-0903 has shown potent inhibition of AXL kinase and other TAM family members in a biochemical kinase assay. ... assays to detect cancer early in blood.
Confirmed PD-L1-positive SCCHN by Ventana SP263 assay; WHO/ECOG performance status of 0 or 1; At least 1 measurable lesion at baseline; No prior exposure to ...
... assays using patient peripheral blood immune cells or serum. A Study of ... cfDNA Assay Prospective Observational Validation for Early Cancer Detection ...
... assay for JAK2 and PD-L1 amplification. Mod Pathol. 2017 Nov; 30 (11):1516-1526 Epub 2017 July 28. View PubMed; Maley CC, Aktipis A, Graham TA, Sottoriva A ...
Jaffe is a researcher and leading authority on myocardial disease biomarkers, and he helped develop and validate the first cardiac troponin I assay, the blood ...
... assays and how to clinically interpret the results obtained with these assays. Dr. Halling's research helps address these needs. Professional highlights.
... assay and discussed with the Sponsor prior to study entry;. - For cohorts 2U, 7U, and 8U: Additional subjects who have relapsed following HCT may be enrolled ...
Tumor PD-L1 expression defined as a CPS ≥ 1 using the FDA- approved pembrolizumab (KEYTRUDA®) assay (local testing). No prior systemic anticancer therapy ...
Note: Tissue sample for mesothelin assay may have been collected prior to, during or after receipt of the frontline chemotherapy; patients will not be ...
Equipment. Tecan Roma (3) liquid handlers for Illumina Infinium BeadArray assays with autoloaders (2). Illumina iScan (4) scanners for Illumina ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.